-
公开(公告)号:EP3389704A1
公开(公告)日:2018-10-24
申请号:EP16822409.5
申请日:2016-12-15
申请人: Institut National de la Santé et de la Recherche Médicale (INSERM) , Université Paul Sabatier Toulouse III , Centre Hospitalier Universitaire de Toulouse
CPC分类号: A61K39/0216 , A61K2039/51 , A61K2039/521 , A61K2039/522
摘要: The present invention concerns a composition comprising at least one prophylactically or therapeutically active agent selected from the group consisting of attenuated Porphyromonas gingivalis, inactivated Porphyromonas gingivalis, a subunit of Porphyromonas gingivalis, a recombinant or isolated immunogenic polypeptide or peptide from Porphyromonas gingivalis or a c DNA from Porphyromonas gingivalis, for use as a vaccine for preventing or treating periodontitis, diabetes, obesity and/or complications thereof in a subject. The present invention also concerns an isolated antibody having specificity for Porphyromonas gingivalis for use for preventing or treating periodontitis, diabetes, obesity and/or complications thereof in a subject.